Search research articles
Contact Us
Filters
Showing results (241-250 of 277) with videos related to
Page
of 28
Sort By:
JAMA
|
June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Thomas Martens, Roy W Beck, Ryan Bailey, et al.
Circulation
|
July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community
Adam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
Journal of the American Heart Association
|
December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
American Journal of Preventive Cardiology
|
August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial
Adam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Diabetes Care
|
September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Diabetes Technology & Therapeutics
|
May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
Toni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
JAMA Cardiology
|
March 25, 2026
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
Sharon L Mulvagh, Silvio E Inzucchi, Nikolaus Marx, et al.
Circulation
|
June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial
Manasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
JAMA Network Open
|
February 17, 2022
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Adam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, et al.
Diabetes Care
|
December 11, 2025
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial
Johannes F E Mann, Nikolaus Marx, John E Deanfield, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 277) with videos related to
Sort By:
Page
of 28
JAMA
|
June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Thomas Martens, Roy W Beck, Ryan Bailey, et al.
Circulation
|
July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community
Adam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
Journal of the American Heart Association
|
December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
American Journal of Preventive Cardiology
|
August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial
Adam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Diabetes Care
|
September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Diabetes Technology & Therapeutics
|
May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
Toni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
JAMA Cardiology
|
March 25, 2026
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
Sharon L Mulvagh, Silvio E Inzucchi, Nikolaus Marx, et al.
Circulation
|
June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial
Manasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
JAMA Network Open
|
February 17, 2022
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Adam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, et al.
Diabetes Care
|
December 11, 2025
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial
Johannes F E Mann, Nikolaus Marx, John E Deanfield, et al.
Page
of 28